Education
About Us
Working with TipRanks
Follow Us
Race Oncology Ltd. (AU:RAC)
:RAC
Total Valuation
Race Oncology Ltd. has a market cap or net worth of AU$698.76M. The enterprise value is AU$190.48M.
Market CapAU$698.76M
Enterprise ValueAU$190.48M
Share Statistics
Race Oncology Ltd. has 174,255,510 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding174,255,510
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Race Oncology Ltd.’s return on equity (ROE) is -0.30 and return on invested capital (ROIC) is 2.30%.
Return on Equity (ROE)-0.30
Return on Assets (ROA)-0.27
Return on Invested Capital (ROIC)2.30%
Return on Capital Employed (ROCE)-0.24
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover0.35
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Race Oncology Ltd. is ―. Race Oncology Ltd.’s PEG ratio is 0.63.
PE Ratio―
PS Ratio33.63
PB Ratio12.69
Price to Fair Value12.69
Price to FCF-44.42
Price to Operating Cash Flow-169.82
PEG Ratio0.63
Income Statement
In the last 12 months, Race Oncology Ltd. had revenue of 6.04M and earned -4.79M in profits. Earnings per share was -0.03.
Revenue6.04M
Gross Profit5.41M
Operating Income-3.77M
Pretax Income-4.79M
Net Income-4.79M
EBITDA-4.43M
Earnings Per Share (EPS)-0.03
Cash Flow
In the last 12 months, operating cash flow was -820.33K and capital expenditures 0.00, giving a free cash flow of -820.33K billion.
Operating Cash Flow-820.33K
Free Cash Flow-820.33K
Free Cash Flow per Share>-0.01
Dividends & Yields
Race Oncology Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.14
52-Week Price Change196.84%
50-Day Moving Average2.05
200-Day Moving Average1.41
Relative Strength Index (RSI)77.25
Average Volume (3m)725.96K
Important Dates
Race Oncology Ltd. upcoming earnings date is Mar 3, 2026, TBA (Confirmed).
Last Earnings DateAug 26, 2025
Next Earnings DateMar 3, 2026
Ex-Dividend Date―
Financial Position
Race Oncology Ltd. as a current ratio of 10.29, with Debt / Equity ratio of 0.00%
Current Ratio10.29
Quick Ratio10.29
Debt to Market Cap0.00
Net Debt to EBITDA3.08
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Race Oncology Ltd. has paid -5.25M in taxes.
Income Tax-5.25M
Effective Tax Rate1.10
Enterprise Valuation
Race Oncology Ltd. EV to EBITDA ratio is -42.75, with an EV/FCF ratio of -41.43.
EV to Sales31.36
EV to EBITDA-42.75
EV to Free Cash Flow-41.43
EV to Operating Cash Flow-41.43
Balance Sheet
Race Oncology Ltd. has AU$18.78M in cash and marketable securities with AU$0.00 in debt, giving a net cash position of AU$18.78M billion.
Cash & Marketable SecuritiesAU$18.78M
Total DebtAU$0.00
Net CashAU$18.78M
Net Cash Per ShareAU$0.11
Tangible Book Value Per ShareAU$0.08
Margins
Gross margin is 89.48%, with operating margin of -62.42%, and net profit margin of -79.22%.
Gross Margin89.48%
Operating Margin-62.42%
Pretax Margin-79.22%
Net Profit Margin-79.22%
EBITDA Margin-73.37%
EBIT Margin-78.03%
Analyst Forecast
The average price target for Race Oncology Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast67.26%